1. Home
  2. CENT vs KOD Comparison

CENT vs KOD Comparison

Compare CENT & KOD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Central Garden & Pet Company

CENT

Central Garden & Pet Company

HOLD

Current Price

$43.66

Market Cap

2.7B

ML Signal

HOLD

Logo Kodiak Sciences Inc

KOD

Kodiak Sciences Inc

HOLD

Current Price

$39.51

Market Cap

2.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CENT
KOD
Founded
1955
2009
Country
United States
United States
Employees
N/A
N/A
Industry
Consumer Specialties
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.7B
2.3B
IPO Year
1996
2018

Fundamental Metrics

Financial Performance
Metric
CENT
KOD
Price
$43.66
$39.51
Analyst Decision
Strong Buy
Buy
Analyst Count
1
7
Target Price
$50.00
$35.43
AVG Volume (30 Days)
93.8K
541.5K
Earning Date
05-06-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
57.41
N/A
EPS
2.84
N/A
Revenue
$3,129,100,000.00
N/A
Revenue This Year
$1.60
N/A
Revenue Next Year
$2.04
N/A
P/E Ratio
$15.62
N/A
Revenue Growth
N/A
N/A
52 Week Low
$28.77
$8.29
52 Week High
$46.97
$47.84

Technical Indicators

Market Signals
Indicator
CENT
KOD
Relative Strength Index (RSI) N/A 47.05
Support Level N/A $38.72
Resistance Level N/A $46.29
Average True Range (ATR) 0.00 2.79
MACD 0.00 -0.48
Stochastic Oscillator 0.00 37.45

Price Performance

Historical Comparison
CENT
KOD

About CENT Central Garden & Pet Company

Central Garden & Pet Co offers solutions that support healthier pets, greener lawns, and thriving gardens. Its products include dog and cat treats, chews, toys, beds, containment, grooming supplies, aquatics, small animal and bird supplies, equine and livestock products, insect control solutions, grass seed, wild bird feed, fertilizers, pest controls, live plants, and packet seeds, sold under brands such as Aqueon, Nylabone, Kaytee, Farnam, Pennington, Ferry Morse, Amdro, and Sevin. The company operates through two segments, Pet and Garden, and sells through retailers, independent stores, eCommerce channels, and professional markets. It has sales and distribution operations mainly across the United States, with additional facilities in Canada and Mexico.

About KOD Kodiak Sciences Inc

Kodiak Sciences Inc has developed a new technology platform, the Antibody Biopolymer Conjugate (ABC) platform, for retinal medicines. Its investigational medicine, tarcocimab tedromer (Zenkuda or tarcocimab), is an anti-VEGF therapy built on Kodiak's proprietary ABC platform. Another investigational medicine, KSI-501, is an anti-interleukin 6, or IL-6, VEGF-trap bispecific therapy built on the ABC platform and is being developed for high-prevalence retinal vascular diseases and intended to address the unmet needs of extended durability and targeting disease biology beyond VEGF for differentiated efficacy. Its third investigational medicine, KSI-101, is a high-strength (100 mg/mL) bispecific protein targeting IL-6 and VEGF.

Share on Social Networks: